• PCN1 CHEMOTHERAPY INDUCED NAUSEA AND VOMITING EVENT RATE AMONG PATIENTS WITH CANCER TREATED WITH HIGHLY OR MODERATELY EMETOGENIC CHEMOTHERAPY AND INITIATED ON PALONOSETRON VERSUS OTHER 5-HT3-RECEPTOR ANTAGONIST ANTI-EMETIC PROPHYLAXIS IN A ...

    May 1, 2011, 00:00

  • CO4 POTENTIAL COST SAVINGS FROM COMPARATIVE EFFECTIVENESS RESEARCH- LESSONS FROM COURAGE STUDY

    May 1, 2011, 00:00

  • PIH27 DIFFERENCES IN PATIENT SATISFACTION WITH PRIMARY CARE AND SPECIALTY CARE

    May 1, 2011, 00:00

  • PND12 LOWER DAILY AVERAGE CONSUMPTION AND GREATER PRESCRIPTION COST SAVINGS OF ARMODAFINIL COMPARED WITH MODAFINIL- A 12-MONTH RETROSPECTIVE DATABASE ANALYSIS

    May 1, 2011, 00:00

  • PSY29 A COMPARISON OF DAILY AVERAGE SUPPLY (DASUP) OF OXYCODONE AND OXYMORPHONE LONG-ACTING ORAL TABLETS

    May 1, 2011, 00:00

  • PCN111 ANALYSIS OF HEALTH OUTCOMES IN BREAST CANCER PATIENTS USING CLUSTER ANALYSIS

    May 1, 2011, 00:00

  • PDB15 SHORT-TERM ASSOCIATION OF ANTIDEPRESSANT DRUG USE, LIFE-STYLE RISK FACTORS AND NEW-ONSET DIABETES

    May 1, 2011, 00:00

  • PHP5 INCENTIVE-BASED INTERVENTIONS – REWARDING PATIENTS FOR GOOD BEHAVIOUR

    May 1, 2011, 00:00

  • PCN125 MELODY BRASIL- TREATMENT PATTERNS AND ASSOCIATED COSTS OF METASTATIC MELANOMA PATIENTS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM (SUS)

    May 1, 2011, 00:00

  • PSY79 CONTENT VALIDITY OF THE MULTIPLE SCLEROSIS INTERNATIONAL QOL (MUSIQOL) QUESTIONNAIRE IN IRAN, EGYPT, MOROCCO, SAUDI ARABIA AND TUNISIA

    May 1, 2011, 00:00

  • PCV12 IMPACT OF POTENTIAL DRUG-DRUG INTERACTIONS (DDIS) ON HEALTH OUTCOMES AND COST TO MEDICAID- THE MONETARY BENFITS OF QUALITY HEALTH CARE

    May 1, 2011, 00:00

  • MC4 LONG TERM PERSISTENCE WITH ACEI/ARB THERAPY AFTER ACUTE MYOCARDIAL INFARCTION- AN ANALYSIS OF THE 2006-2007 MEDICARE 5% NATIONAL SAMPLE DATA

    May 1, 2011, 00:00

  • PMH9 RISK OF DEATH IN DUAL ELIGIBLE NURSING HOME RESIDENTS USING ANTIPSYCHOTIC AGENTS

    May 1, 2011, 00:00

  • PCV30 A META-ANALYSIS OF RISK FACTORS TO DEVELOP CARDIOVASCULAR EVENTS AND STROKE IN SUBJECTS EXPOSED TO ENVIROMENTAL TOBACCO SMOKE

    May 1, 2011, 00:00

  • PSY65 CHARACTERISTICS OF GOLIMUMAB UTILIZATION IN A LARGE NATIONAL PAYER DATABASE

    May 1, 2011, 00:00

  • PIH25 IMPACT OF PATIENT BEHAVIORS AND ATTITUDES ON TERIPARATIDE ADHERENCE IN A MEDICARE PART D POPULATION

    May 1, 2011, 00:00

  • PCN135 ECONOMIC CONSEQUENCES OF PREVENTABLE BLADDER TUMOR RECURRENCES IN NON-MUSCLE INVASIVE BLADDER CANCER

    May 1, 2011, 00:00

  • PDB8 EFFECTIVENESS AND ADHERENCE WITH FIXED-DOSE COMBINATION (FDC) VERSUS COADMINISTERED DUAL THERAPY (CDT) ANTIHYPERGLYCEMIC REGIMENS- A META-ANALYSIS

    May 1, 2011, 00:00

  • PCN115 A CROSS-COUNTRY COMPARISON OF SECOND-LINE MULTIPLE MYELOMA TREATMENTS

    May 1, 2011, 00:00

  • PIN33 COST-UTILITY ANALYSIS OF RALTEGRAVIR IN HIV-INFECTED TREATMENT NAïVE PATIENTS IN SWEDEN

    May 1, 2011, 00:00

  • CN2 ESTIMATED EFFECTS OF THE NATIONAL BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM ON CERVICAL CANCER MORTALITY

    May 1, 2011, 00:00

  • PHP87 IMPACT OF PRESCRIPTION MONITORING PROGRAMS ON CONTROLLED SUBSTANCE PRESCRIBING BEHAVIOR

    May 1, 2011, 00:00

  • PMS37 INDIRECT COMPARISON OF ADALIMUMAB VERSUS ETANERCEPT FOR THE TREATMENT OF PSORIATIC ARTHRITIS

    May 1, 2011, 00:00

  • PSU20 IS THERE INDICATION BIAS OF RETROSPECTIVE OBSERVATIONAL STUDY?

    May 1, 2011, 00:00

  • PDB75 THE IMPACT OF HOSPITAL DAYS ON CALCULATION OF PDC FOR DIABETES MEDICATIONS

    May 1, 2011, 00:00

  • PHP68 THE 15 YEARS EXPERIENCE OF NEW DRUGS ADOPTION AND REIMBURSEMENT IN TAIWAN'S NATIONAL HEALTH INSURANCE

    May 1, 2011, 00:00

  • PHP71 IMPACT OF THE MEDICARE PART D COVERAGE GAP ON PRESCRIPTION DRUG UTILIZATION AND MEDICATION ADHERENCE

    May 1, 2011, 00:00

  • PMS58 BURDEN OF RHEUMATOID ARTHRITIS DISEASE FLARES

    May 1, 2011, 00:00

  • PMS49 ADOPTION, CHOICE, AND UTILIZATION OF BIOLOGIC THERAPIES FOR RHEUMATOID ARTHRITIS IN THE MEDICARE POPULATION

    May 1, 2011, 00:00

  • PHP22 ASSOCIATION OF SELF-REPORTED HEALTH STATUS WITH COST-RELATED MEDICATION NONADHERENCE AND OUT-OF-POCKET PHARMACY SPENDING AMONG SENIOR MEDICARE BENEFICIARIES

    May 1, 2011, 00:00

  • PCV69 IMPACT OF COMMUNITY PHARMACIST-LED COUNSELING ON IMPROVING MEDICATION ADHRERENCE

    May 1, 2011, 00:00

  • PND24 QUALITY OF LIFE USING TREATMENTS FOR PARKINSON'S DISEASE- AN ECONOMIC COMPARISON BETWEEN ROPINIROLE AND LEVODOPA/CARBIDOPA

    May 1, 2011, 00:00

  • PHP20 MEDICATION USE SURVEY OF INPATIENTS WITH BASIC MEDICAL INSURANCE (2010)

    May 1, 2011, 00:00

  • PRS13 ECONOMIC CONSEQUENSES OF USING TULATHROMYCIN, FLORFENICOL, AND TILMICOSIN FOR TREATMENT OF CATTLE AT HIGH RISK OF DEVELOPING BOVINE RESPIRATORY DISEASE IN UNITED STATES FEEDLOTS

    May 1, 2011, 00:00

  • IN1 MEASUREMENT OF SYMPTOMS AND IMPACT OF INFLUENZA- DEVELOPMENT OF THE SYMPTOM INTENSITY AND IMPACT OF INFLUENZA QUESTIONNAIRE (FLU-IIQ)

    May 1, 2011, 00:00

  • PIH37 DUAL VETERAN HEALTH ADMINISTRATION AND MEDICARE USE AND AMBULATORY CARE SENSITIVE HOSPITALIZATIONS

    May 1, 2011, 00:00

  • PHP33 IMPACT OF PHARMACY AND MEDICAL PLAN INTEGRATION ON OVERALL MEDICAL COSTS

    May 1, 2011, 00:00

  • PIN25 COST-EFFECTIVENESS ANALYSIS OF THE INTRODUCTION OF THE VARICELLA VACCINE IN COLOMBIA

    May 1, 2011, 00:00

  • PMS20 HEALTH CARE RESOURCES UTILIZATION IN THE MANAGEMENT OF JUVENILE IDIOPATHIC ARTHRITIS- ANALYSES WITH THE RAMQ DATABASE

    May 1, 2011, 00:00

  • PCN40 HEALTH CARE UTILIZATION AND COSTS OF RESECTED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) IN AN INCIDENT COHORT OF PATIENTS IN THE UNITED KINGDOM

    May 1, 2011, 00:00

  • PGI4 PREDICTORS OF HEPATITIS C TREATMENT INITIATION

    May 1, 2011, 00:00

  • PMH53 ASSESSING THE IMPACT OF MAJOR DEPRESSIVE DISORDER (MDD) ON FAMILY FUNCTIONING- DEVELOPMENT OF THE DEPRESSION AND FAMILY FUNCTIONING SCALE

    May 1, 2011, 00:00

  • PIH30 POSTPARTUM DEPRESSION IN VULNERABLE PEOPLE IN SOUTH KOREA

    May 1, 2011, 00:00

  • PDB22 INSULIN GLARGINE PLUS OHAS VERSUS BIPHASIC INSULIN IN TYPE-2 DIABETES – A COST COMPARISON

    May 1, 2011, 00:00

  • PCN86 A Q-TWIST ANALYSIS COMPARING PANITUMUMAB PLUS BEST SUPPORTIVE CARE (BSC) WITH BSC ALONE IN PATIENTS WITH WILD-TYPE KRAS METASTATIC COLORECTAL CANCER

    May 1, 2011, 00:00

  • PSY37 THE PAIN MANAGEMENT IS ALWAYS A PUBLIC HEALTH CHALLENGE

    May 1, 2011, 00:00

  • PSY7 A NOVEL MECHANISM OF CAPTURING POST-MARKETING SAFETY INFORMATION ON RECOMBINANT FACTOR VIIA (RFVIIA) IN THE RARE DISORDER ACQUIRED HEMOPHILIA- THE ACQUIRED HEMOPHILIA SURVEILLANCE (AHS) PROJECT

    May 1, 2011, 00:00

  • PSS4 SYSTEMATIC REVIEW OF THE EPIDEMIOLOGIC LITERATURE ON ATOPIC DERMATITIS IN CHILDREN

    May 1, 2011, 00:00

  • PUK14 A MARKOV MODEL COMPARING SACRAL NEUROMODULATION AND BOTULINUM TOXIN-A FOR MEDICARE PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER REFRACTORY TO CONSERVATIVE CARE

    May 1, 2011, 00:00

  • PCV23 COMPARING THE EFFECTIVENESS OF ROSUVASTATIN AND ATORVASTATIN IN PREVENTING CARDIOVASCULAR OUTCOMES- ESTIMATES USING THE ARCHIMEDES MODEL

    May 1, 2011, 00:00

  • PHP86 IRRATIONAL USE OF ANTIBIOTICS AND ROLE OF PHARMACISTS- AN INSIGHT FROM A QUALITATIVE STUDY IN NEW DELHI, INDIA

    May 1, 2011, 00:00

  • PIH36 DRUG PRESCRIBING BEHAVIOR FOR THE TREATMENT OF HEAVY MENSTRUAL BLEEDING

    May 1, 2011, 00:00

  • PHP50 MIXED EVIDENCE FOR THE ”HEALTHY ADHERER EFFECT” IN A SAMPLE OF 22,070 ADULTS WITH CHRONIC DISEASE IN THE UNITED STATES

    May 1, 2011, 00:00

  • PMD39 MINI-HTA TRENDS FOR MEDICAL DEVICES IN THE NORDICS

    May 1, 2011, 00:00

  • PMH73 RETROSPECTIVE ANALYSIS OF THE IMPACT OF PERSISTENCE ON HEALTH CARE CHARGES AMONG OPIOID-DEPENDENT PATIENTS TREATED WITH BUPRENORPHINE/NALOXONE USING AN INSURANCE DATABASE IN THE UNITED STATES

    May 1, 2011, 00:00

  • PSS22 SYSTEMATIC REVIEW OF THE QUALITY OF LIFE LITERATURE IN CHILDREN WITH ATOPIC DERMATITIS

    May 1, 2011, 00:00

  • PHP35 DECISION MAKING IN BRAZIL BASED ON HEALTH TECHNOLOGY ASSESSMENT- THE GOOD, THE BAD, AND THE FUTURE

    May 1, 2011, 00:00

  • PDB20 BUDGET IMPACT ANALYSIS OF THE INTRODUCTION OF SAXAGLIPTIN IN THE TREATMENT OF TYPE-2 DIABETES IN CHILE

    May 1, 2011, 00:00

  • CE1 COST-EFFECTIVENESS SENSITIVITY ANALYSIS METHODS- A COMPARISON OF ONE-WAY SENSITIVITY, ANALYSIS OF COVARIANCE, AND EXPECTED VALUE OF PARTIAL PERFECT INFORMATION

    May 1, 2011, 00:00

  • PIH23 A SYSTEMATIC LITERATURE REVIEW OF BEHAVIORAL RISK FACTORS ASSOCIATED WITH INITIAL MEDICATION ADHERENCE

    May 1, 2011, 00:00

  • PSU9 ECONOMIC EVALUATION OF THE CURRENT TREND TOWARDS MORE UNCEMENTED FIXATION IN PRIMARY HIP ARTHROPLASTIES AND THE POTENTIAL IMPACT OF CHANGES OF THE DEVELOPMENT IN ENGLAND AND WALES

    May 1, 2011, 00:00

  • PUK11 UPDATED ECONOMIC ANALYSIS OF FESOTERODINE RELATIVE TO TOLTERODINE AND SOLIFENACIN FOR THE TREATMENT OF OVERACTIVE BLADDER- THE SWEDISH PERSPECTIVE

    May 1, 2011, 00:00

  • PHP30 CAN PRICING SCHEMES IMPROVE MARKET ACCESS FOR INNOVATIVE HIGH PRICED DRUGS?

    May 1, 2011, 00:00

  • PCN6 BREAST, PROSTATE AND COLORECTAL CANCER SCREENING BEHAVIOR AND INCIDENCE OF LATE STAGE CANCER DIAGNOSIS IN ELDERLY WEST VIRGINIANS

    May 1, 2011, 00:00

  • PSY55 NATIONAL TRENDS IN ANTI-OBESITY MEDICATION USE FROM 2002 TO 2007

    May 1, 2011, 00:00

  • PCV106 RE-HOSPITALIZATION RATES OF ACUTE CORONARY SYNDROME PATIENTS IN REAL WORLD CLINICAL PRACTICE- OBSERVATIONS FROM A NATIONAL ADMINISTRATIVE CLAIMS DATA

    May 1, 2011, 00:00

  • PSS7 MEDICAL CARE COSTS ASSOCIATED WITH VISION LOSS IN TAIWAN

    May 1, 2011, 00:00

  • PMD40 METHODOLOGICAL CONSIDERATIONS IN MODELING THE ECONOMIC VALUE OF DIAGNOSTIC ACCURACY

    May 1, 2011, 00:00

  • EV2 PAYERS AND PROS- BEYOND QOL

    May 1, 2011, 00:00

  • PSY54 APPLICATION OF THE NON-LINEAR BLINDER-OAXACA DECOMPOSITION TO STUDY RACIAL/ETHNIC DISPARITIES IN ANTI-OBESITY MEDICATION USE

    May 1, 2011, 00:00

  • PIH7 POTENTIALLY INAPPROPRIATE MEDICATION USE AMONG OLDER ADULTS IN THE UNITED STATES IN 2007

    May 1, 2011, 00:00

  • DS3 AVAILABILITY OF LABORATORY RESULTS DATA IN A CLAIMS DATABASE IN THE UNITED STATES

    May 1, 2011, 00:00

  • PUK18 THE IMPACT OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) ON PATIENTS' HEALTH RELATED QUALITY OF LIFE (HRQOL)- DEVELOPMENT OF A CONCEPTUAL FRAMEWORK

    May 1, 2011, 00:00

  • PCV48 COST-EFFECTIVENESS ANALYSIS OF ANTIARRHYTHMIC THERAPIES FOR THE TREATMENT OF SUPRAVENTRICULAR TACHYCARDIA AND SURGICALLY INDUCED TACHYCARDIAS AND HYPERTENSION

    May 1, 2011, 00:00

  • PMS31 TITLE- THE RELATIVE COST-EFFECTIVENESS OF THE MOST COMMON NON-SURGICAL TREATMENTS FOR NECK PAIN

    May 1, 2011, 00:00

  • PUK12 COST-EFFECTIVENESS OF TOLTERODINE AS TREATMENT FOR OVERACTIVE BLADDER (OAB) IN ADULT MEXICAN PATIENTS

    May 1, 2011, 00:00

  • MD2 PRESCRIPTION DRUG COST AND USE IN THE MEDICARE PART D POPULATION - USES OF A NEW LIMITED DATA SET

    May 1, 2011, 00:00

  • PCV18 MEDICATION ADHERENCE AND HOSPITALIZATION AMONG CHRONIC HEART FAILURE MEDICARE BENEFICIARIES WITH AND WITHOUT DEPRESSION

    May 1, 2011, 00:00

  • PMH64 COMPARISON OF THE RISPERIDONE EQUIVALENT DOSES FOR THE 9 MOST FREQUENT TYPICAL AND ATYPICAL ANTIPSYCHOTICS IN PATIENTS DIAGNOSED WITH SCHIZOPHRENIA BASED ON PRODUCT LABELS WITH ACTUAL DOSAGES PRESCRIBED IN A LARGE NATIONAL DATABASE

    May 1, 2011, 00:00

  • PSU8 PATTERNS OF ACUTE CLOPIDOGREL USE AND INPATIENT COSTS IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFTING

    May 1, 2011, 00:00

  • PIN35 CLINICAL EFFECTIVENESS AND COST UTILITY OF ENTECAVIR VERSUS LAMIVUDINE AND ADEFOVIR IN CHRONIC HEPATITIS B VIRUS (HBV) PATIENTS IN MEXICO

    May 1, 2011, 00:00

  • PMH23 COMPARISON OF HEALTH CARE COSTS AND UTILIZATIONS BETWEEN PATIENTS WHO WERE TREATED WITH AND WITHOUT MEDICATION FOR OPIOID DEPENDENCY

    May 1, 2011, 00:00

  • PMS60 PATIENT OUTCOMES ASSOCIATED WITH BIOLOGIC INFUSION SITE OF CARE FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

    May 1, 2011, 00:00

  • PDB6 LONG-TERM EFFECTIVENESS OF MANAGING DIABETES WITH THE CHRONIC CARE MODEL- SIMULATIONS PERFORMED USING ARCHES

    May 1, 2011, 00:00

  • PCN128 LINKING MEDICARE, MEDICAID AND CANCER REGISTRY DATA TO STUDY BURDEN OF CANCERS IN WEST VIRGINIA (FUNDING- AHRQ - R24 HS018622-01)

    May 1, 2011, 00:00

  • PMH76 PHARMACIST AND PHARMACY STAFF KNOWLEDGE AND ATTITUDES TOWARDS SUICIDE AND SUICIDE PREVENTION AFTER A NATIONAL VA TRAINING PROGRAM

    May 1, 2011, 00:00

  • PIH19 COSTS AND EFFECTS OF A MULTIFACETED INTERVENTION TO IMPROVE THE QUALITY OF CARE OF CHILDREN IN DISTRICT HOSPITALS IN KENYA

    May 1, 2011, 00:00

  • PSU5 LONG-TERM CLINICAL SAFETY OF LASIK AND SURFACE ABLATION IN SOUTH KOREA THROUGH LINKAGE OF RETROSPECTIVE COHORT AND NATIONWIDE CLAIMS DATABASE

    May 1, 2011, 00:00

  • PCN75 ECONOMIC EVALUATION OF DASATINIB IN CHRONIC MYELOGENOUS LEUKAEMIA PATIENTS RESISTANT TO IMATINIB IN PERU, COMPARED TO NILOTINIB AND HIGH DOSES OF IMATINIB

    May 1, 2011, 00:00

  • PDB74 BETA-VERIFICATION OF A DIABETES MODELING FRAMEWORK AGAINST PUBLISHED COHORT TRIALS

    May 1, 2011, 00:00

  • SB2 ZEROS AND NON-REPORTED HEALTH CARE AND WORKPLACE PRODUCTIVITY DATA- AN APPLICATION OF TWO-STAGE ESTIMATION TECHNIQUES MEASURING INPATIENT COSTS AND ABSENTEEISM ASSOCIATED WITH LOW BACK AND NECK PAIN

    May 1, 2011, 00:00

  • PCN70 USING PHARMACOECONOMIC MODELING TO DETERMINE A VALUE-BASED PRICE OF NEW CANCER DRUGS IN MALAYSIA

    May 1, 2011, 00:00

  • PIH17 COST-EFFECTIVENESS OF ABLE A FUNCTIONAL PROGRAM TO DECREASE MORTALITY IN COMMUNITY-DWELLING OLDER ADULTS

    May 1, 2011, 00:00

  • PGI23 WORK PRODUCTIVITY AMONG GENOTYPE 1 HEPATITIS C VIRUS (HCV) TREATMENT-NAÏVE PATIENTS RECEIVING TELAPREVIR-BASED TREATMENT REGIMENS- RESULTS FROM ADVANCE AND ILLUMINATE STUDIES

    May 1, 2011, 00:00

  • PCN63 EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION TESTING AND FIRST LINE TREATMENT WITH GEFITINIB IS A DOMINANT STRATEGY IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)

    May 1, 2011, 00:00

  • PHP31 REVIEW OF HIGHLY SPECIALIZED MEDICAL SERVICES IN KAZKAHSTAN WITHIN AN INTRODUCTIN OF UNIFIED NATIONAL HEALTH SYSTEM

    May 1, 2011, 00:00

  • PCN82 IMPACT OF OPTIMAL CML RESPONSE ON PATIENT SATISFACTION AND QUALITY OF LIFE- A PATIENT SURVEY FROM THE ASSOCIATION OF CANCER ONLINE RESOURCES (ACOR) DATABASE

    May 1, 2011, 00:00

  • PDB62 RELATIONSHIP BETWEEN SOCIAL AND ECONOMIC FACTORS AND ANTIDIABETIC MEDICATION PRESCRIBING PATTERNS

    May 1, 2011, 00:00

  • PSY40 EPIDEMIOLOGY OF HEREDITARY COAGULOPATHIES IN UKRAINE- PATIENT-REPORTED DATA

    May 1, 2011, 00:00

  • PCV1 DOES ROUTE OF ADMINISTRATION FOR ESTROGEN HORMONE THERAPY IMPACT RISK OF VENOUS THROMBOEMBOLISM- ESTRADIOL TRANSDERMAL SYSTEM VERSUS ORAL ESTROGEN-ONLY HORMONE THERAPY

    May 1, 2011, 00:00

  • PSY8 DIRECT AND INDIRECT COSTS OF PRIVATELY-INSURED PATIENTS TREATED WITH OXYMORPHONE EXTENDED-RELEASE OR OXYCODONE CONTROLLED-RELEASE TABLETS

    May 1, 2011, 00:00

  • PMS39 MOST EFFECTIVE ADHERENCE-ENHANCING INTERVENTIONS FOR OSTEOPOROSIS MEDICATIONS

    May 1, 2011, 00:00

  • PMH84 PERFORMANCE OF TWO INSTRUMENTAL VARIABLES TO EXAMINE THE RISK OF DEATH IN DUAL ELIGIBLE ELDERLY NURSING HOME RESIDENTS USING ANTIPSYCHOTIC AGENTS

    May 1, 2011, 00:00

  • PCN15 CORRELATES FOR HUMAN PAPILLOMA VIRUS VACCINATION UPTAKE IN A LARGE HEALTH ORGANIZATION IN ISRAEL

    May 1, 2011, 00:00

  • PIN22 COST-EFFECTIVENESS OF A CATCH-UP DOSE OF HEPATITIS B VACCINE IN COLOMBIAN ADOLESCENTS

    May 1, 2011, 00:00

  • PCV60 MEDICATION ADHERENCE, PERSISTENCE, AND HEALTH CARE COSTS FOR PATIENTS INITIATING STATIN THERAPY IN A MANAGED CARE POPULATION

    May 1, 2011, 00:00

  • PRS39 EFFECT OF BIOMASS SMOKE ON CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN RURAL LOCALITIES OF COLOMBIA

    May 1, 2011, 00:00

  • PMH27 IDENTIFICATION AND COST OF TREATMENT-RESISTANT DEPRESSION USING A CLAIMS SIGNATURE

    May 1, 2011, 00:00

  • PDB60 EFFECT OF MEDICARE PART D COVERAGE GAP ON MEDICATION CONSUMPTION BEHAVIORS- CASE OF ORAL ANTI-DIABETIC MEDICATIONS

    May 1, 2011, 00:00

  • PCN123 A SYSTEMATIC REVIEW OF TREATMENT GUIDELINES FOR METASTATIC COLORECTAL CANCER

    May 1, 2011, 00:00

  • PCV93 HEALTH EXPENDITURE COMPARISON OF METOPROLOL SUCCINATE VS METOPROLOL TARTARATE

    May 1, 2011, 00:00

  • PHP38 UTILIZATION, PRICE AND SPENDING OF ANTI-TUMOR NECROSIS FACTOR BIOLOGICS IN THE UNITED STATES MEDICAID PROGRAM

    May 1, 2011, 00:00

  • PSU22 A PATIENT-BASED QUESTIONANIRE TO ASSESS OUTCOMES OF FOOT SURGERY- VALIDATION IN THE CONTEXT OF SURGERY FOR HALLUX VALGUS

    May 1, 2011, 00:00

  • PMH15 IMPACT OF ADHERENCE TO FIRST THERAPY ON THE RISK OF ANTIDEPRESSANT SWITCHING

    May 1, 2011, 00:00

  • PRM23 MEASURING THE IMPACT OF PREVIOUS TREATMENT CYCLES ON HEALTH UTILITY IN PATIENTS RECEIVING BOTULINUM TOXIN TYPE A (BONTA) IN A PROSPECTIVE OBSERVATIONAL COHORT STUDY- MOBILITY STUDY

    May 1, 2011, 00:00

  • PRM22 STAGES OF NON-PERSISTENCE- A NOVEL WAY OF FRAMING LONGITUDINAL PERSISTENCE TO CHRONIC MEDICATIONS

    May 1, 2011, 00:00

  • PDB42 ADHERENCE TO ROUTINE OR STRUCTURED GLUCOSE MONITORING- A QUALITATIVE EVALUATION FROM THE STEP STUDY

    May 1, 2011, 00:00

  • PMS50 PATTERNS OF TREATMENT UTILIZATION FOR OSTEOPOROSIS IN ELDERLY WOMEN RESIDING IN THE COMMUNITY AND IN LONG-TERM CARE FACILITIES

    May 1, 2011, 00:00

  • PCN38 FIRST-YEAR COSTS FOR THE 19 MOST COMMON CANCER DIAGNOSES IN ONTARIO

    May 1, 2011, 00:00

  • PCV20 PERSISTENCE WITH STATINS AND PRIMARY PREVENTION OF CARDIOVASCULAR EVENTS- A POPULATION-BASED COHORT STUDY

    May 1, 2011, 00:00

  • PMH48 AMBER TODD

    May 1, 2011, 00:00

  • PCN74 UTILISATION OF DRUGS INVOLVED IN TREATMENT OF STAGE I AND STAGE II BREAST CANCER IN SLOVAK REPUBLIC

    May 1, 2011, 00:00

  • PCN137 COMPREHENSIVE REVIEW OF MANAGEMENT EFFICIENCY STRATEGIES AMONG ONCOLOGY PRACTICES- EXISTING EVIDENCE AND OPPORTUNITIES FOR FUTURE RESEARCH

    May 1, 2011, 00:00

  • PDB72 TWO-WAY INTERACTION EFFECT ANALYSIS OF DIABETES COMPLICATIONS ON HEALTH COSTS AND HEALTH OUTCOMES IN MEDICARE INPATIENTS

    May 1, 2011, 00:00

  • PMH83 ESTIMATING SAMPLE SIZE FOR PSYCHOMETRIC STUDIES USING CONFIRMATORY FACTOR ANALYSIS

    May 1, 2011, 00:00

  • PUK23 METHODOLOGICAL CONSIDERATIONS FOR COST-EFFECTIVENESS ANALYSIS OF ONABOTULINUMTOXINA IN PATIENTS WITH NEUROGENIC DETRUSOR OVERACTIVITY

    May 1, 2011, 00:00

  • PMH35 COMPARISONS OF MENTAL HEALTH-RELATED MEDICAL CARE UTILIZATION AND COSTS FOLLOWING THE INITIATION OF ORAL VERSUS LONG-ACTING INJECTABLE RISPERIDONE IN PATIENTS WITH SCHIZOPHRENIA

    May 1, 2011, 00:00

  • PMH85 A SCHIZOPHRENIA OR BIPOLAR TYPE I DISORDER REGISTRY- LESSONS LEARNED FROM CONDUCTING A REGISTRY STUDY WITH SAFETY NET PROVIDERS

    May 1, 2011, 00:00

  • PDB19 ECONOMIC ASSESSMENT OF CONVERSION TO INSULIN PEN DEVICES IN A LONG TERM CARE FACILITY CHAIN

    May 1, 2011, 00:00

  • PCN49 THE RELATIONSHIP OF AGE AND SEX WITH COST OF TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA IN UKRAINE

    May 1, 2011, 00:00

  • PRS42 CONCOMITANT ASTHMA MEDICATION USE IN PATIENTS USING OMALIZUMAB- RESULTS FROM THREE LARGE INSURANCE CLAIMS DATABASES

    May 1, 2011, 00:00

  • PCN25 BUDGET-IMPACT OF ERIBULIN FOR THIRD-LINE TREATMENT OF METASTATIC BREAST CANCER IN A UNITED STATES MANAGED CARE SETTING

    May 1, 2011, 00:00

  • CE3 COST-EFFECTIVENESS ANALYSIS AND BUDGET IMPACT ASSESSMENT- A GRAPHICAL WAY TO COMBINE THE TWO FOR THE AID OF DECISION-MAKERS

    May 1, 2011, 00:00

  • PMH51 BASELINE RESULTS FROM BEAT THE BLUES

    May 1, 2011, 00:00

  • PSY22 ANALYSING THE BENEFITS AND COST SAVING OF ORAL VERSUS IV FLUDARABINE FOR MANAGEMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL)

    May 1, 2011, 00:00

  • PRM34 EVALUATING THE SCREENING ABILITY OF PATIENT-REPORTED OUTCOME INSTRUMENTS

    May 1, 2011, 00:00

  • PRM30 RESULTS FROM A NEW VISUAL ANALOGUE SCALE PROTOCOL FOR EQ-5D VALUATIONS

    May 1, 2011, 00:00

  • IN4 CARDIOVASCULAR DISEASE SCREENING IN HIV-INFECTED PATIENTS – A COST-EFFECTIVENESS ANALYSIS

    May 1, 2011, 00:00

  • PIN52 MAPPING STATE AND FEDERAL IMMUNIZATION RECORDS POLICIES

    May 1, 2011, 00:00

  • PSS5 WHAT INFLUENCES DENTAL CARE AMONG CHILDREN?

    May 1, 2011, 00:00

  • PMD6 READMISSION RATES AND COSTS ASSOCIATED WITH FIBRIN SEALANT USE AMONG PATIENTS UNDERGOING ORTHOPEDIC SURGERY

    May 1, 2011, 00:00

  • PMH69 HEALTH CARE RESOURCE UTILIZATION AMONG PATIENTS WITH BIPOLAR DISORDER- RETROSPECTIVE DATA FROM A LARGE MULTINATIONAL LONGITUDINAL STUDY (WAVE-BD)

    May 1, 2011, 00:00

  • PCV46 LONG-TERM COSTS AND HEALTH OUTCOMES OF TREATING ACUTE CORONARY SYNDROME PATIENTS WITH TICAGRELOR BASED ON THE EU LABEL - COST-EFFECTIVENESS ANALYSIS BASED ON THE PLATO STUDY

    May 1, 2011, 00:00

  • PSS26 PATIENT'S EVALUATION OF THE QUICKNESS OF ACTION OF GINGIVAL INFLAMMATION TREATMENTS

    May 1, 2011, 00:00

  • PND8 INCIDENCE RATES OF SUBARACHNOID HEMORRHAGE IN PATIENTS WITH UNRUPTURED ANEURYSM IN SOUTH KOREA FROM 2006-2009

    May 1, 2011, 00:00

  • PMD38 META ANALYSIS OF THE IMPACT OF HEALTH INFORMATION TECHNOLOGY ON MEDICATION SAFETY IN HOSPITALS- AN INTERRUPTED TIME SERIES STUDY

    May 1, 2011, 00:00

  • PMS22 COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN MEXICO

    May 1, 2011, 00:00

  • PRM45 PILOT TESTING TRANSLATIONS OF PRO MEASURES WITH SENSITIVE POPULATIONS

    May 1, 2011, 00:00

  • PHP81 CAREGIVER WELL-BEING AND HEALTH CARE ACCESS AND QUALITY AMONG CHILDREN WITH CHRONIC PHYSICAL AND MENTAL CONDITIONS

    May 1, 2011, 00:00

  • PMH24 COMPARISON OF HEALTH CARE COSTS AND UTILIZATIONS BETWEEN PATIENTS WHO WERE TREATED WITH PHARMACOLOGICAL AND NON-PHARMACOLOGICAL SUBSTANCE MEDICATIONS FOR ALCOHOL DEPENDENCY

    May 1, 2011, 00:00

  • PMS70 A COMPARISON OF NON-RESPONDER IMPUTATION AND LAST-OBSERVATION-CARRIED-FORWARD ANALYSIS METHODS IN RHEUMATOID ARTHRITIS CLINICAL TRIALS

    May 1, 2011, 00:00

  • PUK2 DUTASTERIDE FOR BENIGN PROSTATIC HYPERPLASIA- A SYSTEMATIC REVIEW AND META-ANALYSIS

    May 1, 2011, 00:00

  • PMH67 CO-PRESCRIBING CHOLINESTERASE INHIBITORS WITH ANTICHOLINERGIC URINARY INCONTINENCE MEDICATIONS

    May 1, 2011, 00:00

  • PMH1 IS STIMULANT OR ATOMOXETINE UTILIZATION ASSOCIATED WITH NEUROLOGICAL ADVERSE EVENTS IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD)? A RETROSPECTIVE ANALYSIS OF PROPENSITY SCORE MATCHED DATA

    May 1, 2011, 00:00

  • PCN34 LONG-TERM DIRECT MEDICAL COSTS IN PATIENTS DIAGNOSED WITH FOLLICULAR LYMPHOMA WHO RECEIVE FRONTLINE CHEMOTHERAPY WITH VERSUS WITHOUT RITUXIMAB - A SEER MEDICARE ANALYSIS

    May 1, 2011, 00:00

  • PIN49 A REVIEW OF EPIDEMIOLOGICAL LITERATURE ON THE BASIC REPRODUCTION NUMBER FOR THE 2009 NOVEL STRAIN OF H1N1

    May 1, 2011, 00:00

  • PHP9 IMPACT OF FREE PRESCRIPTIONS IN WALES ON PRESCRIBING - A THIN DATABASE STUDY

    May 1, 2011, 00:00

  • PCV110 DEVELOPMENT AND VALIDATION OF A SHORT PRO MEASURE OF HEALTH STATUS FOR INDIVIDUALS WITH ACUTE MYOCARDIAL INFARCTION- THE MYOCARDIAL INFARCTION DIMENSIONAL ASSESSMENT SCALE (MIDAS)

    May 1, 2011, 00:00

  • PMS62 ASSOCIATION OF SATISFACTION WITH SUBCUTANEOUS ANTI-TNF THERAPY AND CLINICAL OUTCOMES, HEALTH STATUS, AND LOST WORK PRODUCTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS

    May 1, 2011, 00:00

  • PMD3 PARTIAL RESPONDERS IN SCHIZOPHRENIA

    May 1, 2011, 00:00

  • PCV10 THE EFFECT OF INTERACTIONS BETWEEN CLOPIDOGREL AND PROTON PUMP INHIBITORS ON ADVERSE CARDIOVASCULAR OUTCOMES IN COMMERCIALLY INSURED PATIENTS WITH ACUTE CORONARY SYNDROME

    May 1, 2011, 00:00

  • PHP2 TRENDS IN AND PREDICTORS OF DISCOUNT GENERIC MEDICATION PROGRAM UTILIZATION

    May 1, 2011, 00:00

  • PRM21 CONVERTING PAPER VERSIONS OF PATIENT REPORTED OUTCOME INSTRUMENTS TO ELECTRONIC VERSIONS- IDENTIFYING THE REQUIRED STEPS

    May 1, 2011, 00:00

  • PIN51 IMPACT OF 2005 MEASLES OUTBREAK IN THE UNITED STATES ON IMMUNIZATION RATE AGAINST MEASLES

    May 1, 2011, 00:00

  • PDB52 A LITERATURE REVIEW OF DIABETES RISK ASSESSMENT TOOLS

    May 1, 2011, 00:00

  • PCN67 ERCC1 EXPRESSION TESTING IN STAGE I NON-SMALL CELL LUNG CANCER- POTENTIAL CLINICAL AND ECONOMIC OUTCOMES

    May 1, 2011, 00:00

  • PMS43 QUALITY OF LIFE AND FIBROMYALGIA - A SYSTEMATIC LITERATURE REVIEW

    May 1, 2011, 00:00

  • PSU11 REDUCTION IN HEALTHCARE UTILIZATION AND EXPENDITURES IN PATIENTS TREATED WITH CATHETER ABLATION FOR ATRIAL FIBRILLATION (AF) IN THE UNITED STATES

    May 1, 2011, 00:00

  • PCV21 EFFECTS OF AZILSARTAN MEDOXOMIL VERSUS VALSARTAN AND OLMESARTAN MEDOXOMIL ON THE ACHIEVEMENT OF SYSTOLIC BLOOD PRESSURE GOALS AMONG HYPERTENSIVE PATIENTS WITH DIABETES

    May 1, 2011, 00:00

  • PMS52 PREDICTORS OF BISPHOSPHONATE PRESCRIPTION IN PATIENTS WITH OSTEOPOROSIS

    May 1, 2011, 00:00

  • PSY14 ECONOMIC IMPACT OF POTENTIAL DRUG-DRUG INTERACTIONS AMONG PATIENTS TAKING OPIOID ANALGESICS

    May 1, 2011, 00:00

  • PMH80 UTILIZATION PATTERN AND TREATMENT ADHERENCE WITH MOOD STABILIZERS AND ATYPICAL ANTIPSYCHOTICS AMONG PEDIATRIC PATIENTS WITH BIPOLAR DISORDER- A RETROSPECTIVE CLAIMS-BASED STUDY

    May 1, 2011, 00:00

  • DM4 EVALUATION OF CLINICAL LABORATORY-PHARMACY LINKAGE DECISION SUPPORT IN THE USE OF POTASSIUM SUPPLEMENTS

    May 1, 2011, 00:00

  • PIN48 TRENDS IN FUNDING OF SPECIALIST VACCINES

    May 1, 2011, 00:00

  • PND34 MAPPING THE INSOMNIA SEVERITY INDEX (ISI) TO THE EQ-5D UTILITIES

    May 1, 2011, 00:00

  • PCN7 COMPARATIVE EFFECTIVENESS ASSESSMENT OF ERLOTINIB VERSUS GEFITINIB IN FIRST-LINE EGFR ACTIVATING MUTATION POSITIVE NON-SMALL CELL LUNG CANCER

    May 1, 2011, 00:00

  • PCV4 TREATMENT PATTERNS, CLINICAL AND ECONOMIC BURDEN OF VENOUS THROMBOEMBOLISM IN ABDOMINAL SURGERY PATIENTS

    May 1, 2011, 00:00

  • PMS54 ESTIMATING THE ECONOMIC BENEFITS OF POSITIVE SHIFTS IN FIBROMYALGIA SEVERITY

    May 1, 2011, 00:00

  • PCV81 SUSTAINING CLINICAL OUTCOMES OVER 24 MONTHS- IS MEDICATION THERAPY MANAGEMENT (MTM) THE ANSWER?

    May 1, 2011, 00:00

  • PSY18 A DECISION ANALYSIS MODEL EXPLORING THE RESULTS OF A PHASE II TRIAL OF ELTROMBOPAG FOR PATIENTS WITH CHRONIC HEPATITIS C, CIRRHOSIS AND THROMBOCYTOPENIA

    May 1, 2011, 00:00

  • EE4 BOOTSTRAPPING USED TO PROVIDE ROBUST MEAN AND VARIANCE ESTIMATES FOR COMPARING PATIENTS TREATED WITH LIRAGLUTIDE TO A LARGE COMPARISON COHORT

    May 1, 2011, 00:00

  • PCN21 PATTERNS OF ANGIOGENESIS INHIBITOR TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) IN IRELAND

    May 1, 2011, 00:00

  • PIH39 THE EFFECT OF ELECTRONIC-MEDICAL-RECORD SYSTEM SOPHISTICATION ON PREVENTIVE HEALTH CARE FOR WOMEN

    May 1, 2011, 00:00

  • PIH11 COST ANALYSIS OF TOTAL PARENTERAL NUTRITION IN THE NEONATAL AND PEDIATRIC CARE IN BELGIAN HOSPITALS

    May 1, 2011, 00:00

  • PDB33 EVALUATING THE COST-EFFECTIVENESS OF SWITCHING FROM INSULIN GLARGINE TO INSULIN DETEMIR IN PATIENTS WITH TYPE-2 DIABETES IN A CHINESE SETTING- A MODELING STUDY BASED ON THE PREDICTIVE STUDY

    May 1, 2011, 00:00

  • PMS17 EVALUATING THE ASSOCIATION BETWEEN SERUM URIC ACID LEVEL AND HEALTH CARE COSTS IN PATIENTS WITH GOUT

    May 1, 2011, 00:00

  • PCV94 ANTICOAGULANT USE, THE PREVALENCE OF BRIDGING AND RELATION TO LENGTH OF STAY AMONG HOSPITALIZED PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION

    May 1, 2011, 00:00

  • PMH62 TREND IN UTILIZATION OF AND SPENDING ON BENZODIAZEPINES IN THE UNITED STATES MEDICAID PROGRAM- 1991-2009

    May 1, 2011, 00:00

  • PSU2 USING ELECTRONIC MEDICAL RECORDS TO IDENTIFY POTENTIAL PREDICTORS FOR BARIATRIC SURGERY SUCCESS

    May 1, 2011, 00:00

  • PCN81 DIVERSITY IN BELIEFS ABOUT THE CAUSES OF CANCER- A QUALITATIVE APPROACH TO EVALUATE CANCER PATIENTS' UNDERSTANDING TOWARDS CANCER AND ITS CAUSES

    May 1, 2011, 00:00

  • PIN9 BUDGET IMPACT MODEL OF ABACAVIR/LAMIVUDINE FOR TREATMENT OF HIV INFECTED PATIENTS IN MEXICO

    May 1, 2011, 00:00

  • PIN24 COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS WITH PALIVIZUMAB AMONG PRETERM INFANTS COVERED BY MEDICAID IN THE UNITED STATES

    May 1, 2011, 00:00

  • PND17 IMPACT OF WALKING AND MOBILITY PROBLEMS ON REQUIREMENT FOR HEALTHCARE AMONG MULTIPLE SCLEROSIS PATIENTS

    May 1, 2011, 00:00

  • PSS10 A COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT FOR THE TREATMENT OF MODERATE AND SEVERE PSORIASIS IN MEXICO

    May 1, 2011, 00:00

  • PCV45 COST-EFFECTIVENESS OF CYP2C9 AND VKORC1 GENOTYPE-GUIDED WARFARIN ANTICOAGULATION CARE- THE IMPLEMENTATION OF DISCRETE EVENT SIMULATION MODEL ON THE NATURAL HISTORY OF VENOUS THROMBOEMBOLISM

    May 1, 2011, 00:00

  • PHP97 PRO LABEL CLAIMS- AN ANALYSIS BASED ON A REVIEW OF PROS AMONG NEW MOLECULAR ENTITIES AND BIOLOGIC LICENSE APPLICATIONS 2006-2010

    May 1, 2011, 00:00

  • DS4 BURDEN OF PROOF…PROOF OF PRINCIPLE- REPLICATION QUANTIFICATION, REPLICATION AND VALIDATION… STANDARDS OF EVIDENCE IN OUTCOMES RESEARCH SURROGATE ENDPOINTS FOR ALL-CAUSE MORTALITY

    May 1, 2011, 00:00

  • PSY16 PROJECTING THE LIFETIME ECONOMIC COSTS OF OBESITY- A BMI TRAJECTORY-BASED MODEL

    May 1, 2011, 00:00

  • PRS37 THE PRICE NEGOTIATION ON PHARMACEUTICALS AFTER THE INTRODUCTION OF POSITIVE LIST SYSTEM IN SOUTH KOREA

    May 1, 2011, 00:00

  • PMD18 THE COST-EFFECTIVENESS OF INITIATING SENSOR-AUGMENTED PUMP THERAPY VERSUS MULTIPLE DAILY INJECTIONS OF INSULIN IN ADULTS WITH TYPE 1 DIABETES- EVALUATING A TECHNOLOGY IN EVOLUTION

    May 1, 2011, 00:00

  • PCV92 CHANGES IN THE PREVALENCE, TREATMENT AND CONTROL OF HYPERTENSION IN GERMANY? A CLINICAL-EPIDEMIOLOGICAL EXAMINATION OF 50,000 PRIMARY CARE PATIENTS WITH THE DETECT STUDY

    May 1, 2011, 00:00

  • PCN29 TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) USING RITUXIMAB (R) WITH FLUDARABINE (F) AND CYCLOPHOSPHAMIDE (C)- ASSESSING THE FINANCIAL IMPACT OF THE ROUTE OF ADMINISTRATION AT PRINCESS MARGARET HOSPITAL (PMH)

    May 1, 2011, 00:00

  • PGI12 DOSE VARIATIONS WITH ADALIMUMAB AND INFLIXIMAB IN THE TREATMENT OF CROHN'S DISEASE- A CANADIAN ASSESSMENT

    May 1, 2011, 00:00

  • PIN41 INFLUENZA VACCINATION RATES AMONG HIGH RISK GROUPS IN THE UNITED STATES

    May 1, 2011, 00:00

  • PCV15 PREDICTORS OF THE COMBINED DIAGNOSIS HYPERLIPIDEMIA AND HYPERTENSION - A NHANES 2007-2008 STUDY

    May 1, 2011, 00:00

  • PHP59 THE AVAILABILITY AND SIGNIFICANCE OF COST-EFFECTIVENESS DATA FOR INFORMING DECISIONS TO ADD NEW DRUGS TO THE NATIONAL LIST OF HEALTH SERVICES IN ISRAEL

    May 1, 2011, 00:00

  • PMD22 COST-EFFECTIVENESS ANALYSIS OF THREE WOUND DRESSINGS FOR THE TREATMENT OF PRESSURE ULCERS FROM THE PUBLIC HOSPITAL PERSPECTIVE

    May 1, 2011, 00:00

  • PRM2 MEASURING DRUG THERAPY GUIDELINES ON OUTCOMES- A TUTORIAL

    May 1, 2011, 00:00

  • PDB24 DIRECT HEALTHCARE AND INDIRECT WORKLOSS COSTS ASSOCIATED WITH THE ADDITION OF ROSIGLITAZONE (RSG) VERSUS SITAGLIPTIN (STG) THERAPY TO METFORMIN (MET)

    May 1, 2011, 00:00

  • PND20 HEALTHCARE UTILIZATION AND COSTS AMONG AD PATIENTS WITH AND WITHOUT DYSPHAGIA

    May 1, 2011, 00:00

  • PMH34 MEASURING THE IMPACT OF PERSISTENCE WITH PSYCHOTROPIC DRUG THERAPY ON TREATMENT COSTS FOR PATIENTS WITH SCHIZOPHRENIA

    May 1, 2011, 00:00

  • PMD34 PREFERENCES FOR GENETIC TESTING TO ASSESS COLON-CANCER RISKS

    May 1, 2011, 00:00

  • PMS27 A COST-EFFECTIVENESS ANALYSIS FROM AN INSTITUTIONAL PERSPECTIVE TO COMPARE ZOLEDRONIC ACID WITH STANDARD OF CARE IN THE PREVENTION OF HIP FRACTURES IN PATIENTS WITH OSTEOPOROSIS

    May 1, 2011, 00:00

  • PND47 THE HEMOPHILIA UTILIZATION GROUP STUDY (HUGS-VB)- HEALTH-RELATED QUALITY OF LIFE IN HEMOPHILIA B

    May 1, 2011, 00:00

  • PUK3 DRUG-INDUCED ACUTE RENAL FAILURE USING THE FDA ADVERSE EVENT REPORTING SYSTEM DATABASE

    May 1, 2011, 00:00

  • DM3 IMPACT OF MONTHLY PRESCRIPTION CAP ON MEDICATION PERSISTENCY AMONG PATIENTS WITH DIABETES, HYPERTENSION, OR HYPERLIPIDEMIA

    May 1, 2011, 00:00

  • PIH8 THE ECONOMIC IMPACT ATTRIBUTABLE TO THE INAPPROPRIATE PRESCRIPTION OF BENZODIAZEPINES IN THE ELDERLY LIVING IN THE COMMUNITY

    May 1, 2011, 00:00

  • PMH17 PREVALENCE OF ANTICHOLINERGIC DRUG PRESCRIBING IN ELDERLY OUTPATIENTS WITH DEMENTIA

    May 1, 2011, 00:00

  • PSY47 WILLINGNESS TO PAY (WTP) FOR WEIGHT LOSS COACHING- RESULTS FROM THE POWER TRIAL

    May 1, 2011, 00:00

  • PMD31 IMPACT OF GASTRIC ELECTRIC STIMULATION ON HEALTH STATE UTILITIES OF DIABETIC GASTROPARESIS PATIENTS- RESULTS FROM A PROSPECTIVE CLINICAL TRIAL

    May 1, 2011, 00:00

  • PRM40 ISSUES CONCERNING THE TRANSLATION OF THE WORD ‘HASSLED' IN THE MORISKY MEDICATION ADHERENCE SCALE (MMAS-8)

    May 1, 2011, 00:00

  • PHP1 USE OF STRUCTURAL EQUATION MODELING TO EXPLAIN CONSUMER BEHAVIOR TOWARDS GENERIC DRUG DISCOUNT PROGRAMS

    May 1, 2011, 00:00

  • PMH7 LIKELIHOOD OF POTENTIAL DRUG-DRUG INTERACTIONS AMONG PERSONS INITIATING THERAPY WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS- EFFECT OF INITIAL SSRI AND OTHER FACTORS

    May 1, 2011, 00:00

  • PSY48 A WORKPLACE HEALTH PROGRAM FOR BRITISH COLUMBIA PUBLIC SERVICE AGENCY (CANADA)

    May 1, 2011, 00:00

  • PMS11 APPLYING THE STRATIFIED PROPENSITY SCORE MATCHING METHOD WHEN ESTIMATING HEALTH CARE COSTS OF RHEUMATOID ARTHRITIS PATIENTS

    May 1, 2011, 00:00

  • PRS28 EVALUATING THE IMPACT OF PHYSICIAN PROVIDED ASTHMA EDUCATION ON ABSENTEEISM IN CHILDREN- USING DATA FROM THE NATIONAL HEALTH INTERVIEW SURVEY (NHIS)

    May 1, 2011, 00:00

  • PUK15 THE COST-EFFECTIVENESS OF LANTHANUM CARBONATE IN THE TREATMENT OF HYPERPHOSPHATEMIA IN DIALYSIS PATIENTS FROM A CANADIAN PERSPECTIVE

    May 1, 2011, 00:00

  • PCN18 AN EPIDEMIOLOGICAL MODEL OF PROSTATE CANCER AND PROGRESSION TO BONE METASTASES IN THE UNITED KINGDOM

    May 1, 2011, 00:00

  • PRS3 RELATIVE EFFECTIVENESS STUDY OF OMALIZUMAB- THE USE OF BEFORE-AFTER COHORT METHODOLOGY FOR COVERAGE WITH EVIDENCE DEVELOPMENT

    May 1, 2011, 00:00

  • PMH82 VALIDATION AND PSYCHOMETRIC EVALUATION OF A BRIEF COMBINED ASSESSMENT OF DEPRESSION AND ANXIETY

    May 1, 2011, 00:00

  • PRM11 WHY ALGORITHM DOESN'T MATTER IN SYNDROMIC SURVEILLANCE- A COMPARISON OF SYNDROME CLASSIFICATION METHODS

    May 1, 2011, 00:00

  • PCV16 MANAGING GROWING POPULATION OF TYPE-2 DIABETES FROM COMMUNITY TO TEACHING HOSPITALS IN CHINA

    May 1, 2011, 00:00

  • PSY76 TREATMENT OF CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS) KNOWLEDGE STUDY (TOCKS)- NOVEL DATA COLLECTION, VIEWING AND DYNAMIC REPORTING MECHANISM

    May 1, 2011, 00:00

  • PSY72 VARIATION BY AGE IN HEALTH-RELATED QUALITY OF LIFE OF PATIENTS INITIATING TREATMENT FOR MYELODYSPLASTIC SYNDROMES

    May 1, 2011, 00:00

  • PDB14 USING HEALTH OUTCOMES MODELING TO ASSESS THE BENEFIT-RISK PROFILE OF EXENATIDE ONCE-WEEKLY VERSUS INSULIN GLARGINE FOR PATIENTS WITH TYPE-2 DIABETES

    May 1, 2011, 00:00

  • PCV33 USE OF SECONDARY DATA SOURCES TO ESTIMATE INPATIENT COSTS AND PAYMENTS FOR ACUTE CORONARY SYNDROME

    May 1, 2011, 00:00

  • PMS16 COST OF RHEUMATOID ARTHRITIS PATIENTS RECEIVING TNF-ANTAGONIST THERAPY FROM THE KOREA NATIONAL HEALTH INSURANCE CLAIMS DATABASE

    May 1, 2011, 00:00

  • OR4 ASSOCIATIONS BETWEEN JOBLESSNESS AND ALL-CAUSE HEALTH SERVICES UTILIZATION IN DIABETIC WORKING AGE ADULTS IN THE UNITED STATES

    May 1, 2011, 00:00

  • PCV52 COST-EFFECTIVNESS STUDY OF CITICOLINE IN PATIENTS WITH ACUTE ISCHEMIC STROKE IN RUSSIA

    May 1, 2011, 00:00

  • PCV68 FACTORS ASSOCIATED WITH NON-ADMINISTRATION OF ORDERED PHARMACOLOGIC VENOUS THROMBOEMBOLISM PROPHYLAXIS DOSES

    May 1, 2011, 00:00

  • PCV17 PREDICTORS OF TIME TO DISCONTINUE BETA-BLOCKER FOLLOWING ACUTE MYOCARDIAL INFARCTION- AN ANALYSIS OF THE MEDICARE 5% NATIONAL SAMPLE DATA 2006-2007

    May 1, 2011, 00:00

  • PRS31 DEVELOPMENT OF A QUESTIONNAIRE ASSESSING THE BURDEN OF PRURITUS

    May 1, 2011, 00:00

  • PRM4 WHAT IS IMPORTANT DURING THE PHARMACOECONOMIC EVALUATION OF CAM (COMPLEMENTARY AND ALTERNATIVE MEDICINE)?—A SURVEY RESEARCH

    May 1, 2011, 00:00

  • PSY5 AN INVESTIGATION INTO THE RELATIONSHIP BETWEEN OBESITY AND SKIN AND SOFT TISSUE INFECTIONS REQUIRING HOSPITALIZATION

    May 1, 2011, 00:00

  • PCN56 COST-EFFECTIVENESS OF TEMSIROLIMUS FOR METASTIC RENAL-CELL CARCINOMA AND POOR PROGNOSIS PATIENTS IN MEXICO

    May 1, 2011, 00:00

  • PSY23 ECONOMIC EVALUATION OF ERYTHROPOIESIS STIMULATING AGENTS IN CRITICALLY ILL TRAUMA PATIENTS

    May 1, 2011, 00:00

  • PSS14 COST-UTILITY ANALYSIS OF RANIBIZUMAB (LUCENTIS®) IN WET-AMD BASED ON REAL-LIFE DATA COLLECTED IN THE HELIOS STUDY AFTER RANIBIZUMAB REIMBURSEMENT IN BELGIUM

    May 1, 2011, 00:00

  • PGI18 FEASIBILITY OF ASSESSING UTILITY BY EQ-5D AND TIME-TRADE-OFF METHODS IN TAIWANESE CHRONIC HEPATITIS B PATIENTS

    May 1, 2011, 00:00

  • PDB63 GEOGRAPHIC VARIATION IN DRUG SPENDING AND ADHERENCE PATTERNS FOR MEDICARE BENEFICIARIES WITH DIABETES

    May 1, 2011, 00:00

  • PHP112 DEFINITIONAL CRITERIA FOR CHRONIC FATIGUE SYNDROME- A CRITICAL REVIEW

    May 1, 2011, 00:00

  • PRM41 IS IT TIME TO ELIMINATE THE ICER? USING NET BENEFITS TO REPORT THE RESULTS OF DETERMINISTIC COST-EFFECTIVENESS ANALYSES

    May 1, 2011, 00:00

  • PIH6 THE DEFINITION AND PREVALENCE OF PSYCHOTROPIC POLYPHARMACY IN MEDICAID CHILDREN AND ADOLESCENTS

    May 1, 2011, 00:00

  • PMS64 PATIENT EXPERIENCE WITH SUBCUTANEOUS ANTI-TNF THERAPY AMONG RHEUMATOID ARTHRITIS PATIENTS

    May 1, 2011, 00:00

  • PGI11 THE ECONOMIC AND QUALITY OF LIFE BURDEN OF ILLNESS IN CHRONIC CONSTIPATION (CC) AND IRRITABLE BOWEL SYNDROME (IBS)- A SYSTEMATIC REVIEW

    May 1, 2011, 00:00

  • PSS19 PSYCHOMETRIC EVALUATION OF THE NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE 25 AND VISUAL FUNCTION QUESTIONNAIRE UTILITY INDEX IN PATIENTS WITH NON-INFECTIOUS INTERMEDIATE AND POSTERIOR UVEITIS

    May 1, 2011, 00:00

  • PIN27 COST-EFFECTIVENESS ANALYSIS OF THE INTRODUCTION OF ACELLULAR PERTUSSIS IN COLOMBIAN ADOLESCENTS

    May 1, 2011, 00:00

  • PCN27 COMPARATIVE BUDGET IMPACT OF FORMULARY INCLUSION OF ZOLEDRONIC ACID AND DENOSUMAB FOR PREVENTION OF SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASES

    May 1, 2011, 00:00

  • PMS25 COST-EFFECTIVENESS OF ABATACEPT OR INFLIXIMAB IN RHEUMATOID ARTHRITIS IN COLOMBIA

    May 1, 2011, 00:00

  • PMS45 WILLINGNESS TO PAY FOR OSTEOPOROSIS TREATMENT TO PREVENT FRACTURE IN KOREAN POPULATION

    May 1, 2011, 00:00

  • PMH41 ECONOMIC EVALUATION OF DESVENLAFAXINE IN THE ACUTE MANAGEMENT OF INPATIENTS WITH MAJOR DEPRESSIVE DISORDER FROM A BRAZILIAN PUBLIC HOSPITAL PERSPECTIVE

    May 1, 2011, 00:00

  • PCN12 RESOURCE UTILIZATION AND PERCEPTIONS OF MAJOR MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA (CML)- RESULTS OF A DELPHI PANEL STUDY

    May 1, 2011, 00:00

  • PHP47 ADVERSE DRUG EVENTS AND ELECTRONIC MEDICAL RECORDS- RESULTS FROM THE 2007-2008 NATIONAL AMBULATORY MEDICAL CARE SURVEY

    May 1, 2011, 00:00

  • PCV61 THE IMPACT OF THE MEDICARE DOUGHNUT HOLE ON MEDICATION USE BEHAVIORS AND HEALTH CARE RESOURCE UTILIZATION AMONG BENEFICIARIES TAKING STATIN MEDICATION

    May 1, 2011, 00:00

  • PND14 BURDEN OF ILLNESS IN THE UNITED STATES FOR ADULT EPILEPSY PATIENTS WITH PARTIAL ONSET SEIZURES RECEIVING ANTI-EPILEPTIC DRUGS

    May 1, 2011, 00:00

  • PMS36 EXAMINING THE RELATIONSHIP BETWEEN MONTHLY OUT-OF-POCKET HEALTHCARE COSTS AND WORK PRODUCTIVITY AMONG INDIVIDUALS WITH RHEUMATOID ARTHRITIS

    May 1, 2011, 00:00

  • PRM3 THE BURDEN OF CAREGIVING- ASSESSING THE STATUS OF CURRENT CLINICAL RESEARCH

    May 1, 2011, 00:00

  • PGI14 PERCEIVED VALUE ASSESSMENT OF ENTECAVIR VERSUS TENOFOVIR IN CHRONIC HEPATITIS B

    May 1, 2011, 00:00

  • PSY58 DISPARITY IN OBESITY MANAGEMENT- UNDER-TREATMENT AMONG ELDERLY POPULATION

    May 1, 2011, 00:00

  • PRM19 NON-RESPONSE BIAS IN A SURVEY ASSESSING PATIENTS' MEDICATION AND HEALTH BELIEFS

    May 1, 2011, 00:00

  • PND41 PARNETING STRESS IN CARING FOR CHILDREN DIAGNOSED WITH NEURO-DEVELOPMENTAL DISORDER

    May 1, 2011, 00:00

  • PCN30 DOES A LACK OF HTA REVIEW LEAD TO HIGHER PRICES FOR HIV TREATMENTS? A COMPARISON WITH ONCOLOGY TREATMENTS

    May 1, 2011, 00:00

  • PMH44 PHYSICAL AND MENTAL HEALTH AS IMPORTANT INPUTS INTO WAGE FUNCTION

    May 1, 2011, 00:00

  • MC1 COMPARISON OF REFILL GAP ANALYSIS METHODOLOGIES IN A POPULATION OF PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ADALIMUMAB OR ETANERCEPT

    May 1, 2011, 00:00

  • PIN47 CRITICAL SUCCESS FACTORS FOR THE UPTAKE OF NOVEL VACCINES ONTO NATIONAL IMMUNUSATION PROGRAMMES

    May 1, 2011, 00:00

  • PRM28 CREATION OF A NEW PSORIASIS QUALITY OF LIFE MEASURE FROM FIVE PREEXISTENT INSTRUMENTS USING RASCH ANALYSIS- THE CALIPSO QUESTIONNAIRE

    May 1, 2011, 00:00

  • PRS24 IMPACT OF MORBIDITY, PSYCHOLOGICAL DISTRESS AND LUNG FUNCTION ON PHYSICAL FUNCTIONING IN A RETIRED POPULATION

    May 1, 2011, 00:00

  • PDB31 BENEFITS AND COSTS OF CONDUCTING SPONSORED CLINICAL TRIALS IN A PUBLICLY FUNDED NEW ZEALAND HOSPITAL- PRE-TRIAL, TRIAL AND FOLLOW-UP

    May 1, 2011, 00:00

  • PMH71 HEALTH CARE RESOURCE UTILIZATION (HRU) AND DIRECT MEDICAL EXPENDITURES (DME) FOR ADULT WOMEN WITH ANXIETY DISORDERS (AD) IN THE UNITED STATES IN 2006 USING MEDICAL EXPENDITURES PANEL SURVEY (MEPS)

    May 1, 2011, 00:00

  • PSU4 SURGEON'S VOLUME-OUTCOMES RELATIONSHIP FOR LOBECTOMIES AND WEDGE RESECTIONS FOR CANCER USING VIDEO-ASSISTED THORACOSCOPIC TECHNIQUES

    May 1, 2011, 00:00

  • PRS6 WATERPIPE SMOKING AMONG JORDANIAN ADULTS- PREDICTORS AND CORRELATES

    May 1, 2011, 00:00

  • PHP102 WHICH CRITERIA ARE USED IN HEALTH CARE DECISIONMAKING AND PRIORITY SETTING? A LITERATURE REVIEW FOR AN INTERNATIONAL SURVEY OF DECISIONMAKERS

    May 1, 2011, 00:00

  • PRS5 CIGARETTE SMOKING AMONG JORDANIAN ADULTS- PREDICTORS AND CORRELATES

    May 1, 2011, 00:00

  • PCV14 DYSPEPSIA AND DISEASE BURDEN AMONG PATIENTS WITH ATRIAL FIBRILLATION (AF)

    May 1, 2011, 00:00

  • PCN3 CARDIOVASCULAR COMORBIDITIES AMONG PATIENTS WITH METASTATIC COLORECTAL CANCER

    May 1, 2011, 00:00

  • PCN80 PATIENT PREFERENCES FOR TOXICITIES ASSOCIATED WITH CHEMOTHERAPIES FOR ADVANCED BREAST CANCER

    May 1, 2011, 00:00

  • PHP114 OPTIMIZING THE ORGANIZATION; MIGRATING HEALTH SERVICES RESEARCH OPERATIONS INTO THE COLLABORATIVE SCIENCE CENTER OF EXCELLENCE

    May 1, 2011, 00:00

  • PND49 MEASUREMENT CHARACTERISTICS OF THE SF-36 IN PARKINSON'S DISEASE

    May 1, 2011, 00:00

  • PND39 MULTIPLE SCLEROSIS PATIENTS REPORT IMPROVEMENTS IN FATIGUE AND COGNITIVE FUNCTIONING AFTER ONE YEAR OF NATALIZUMAB TREATMENT

    May 1, 2011, 00:00

  • PIN43 UTILIZATION AND SPENDING OF ANTIFUNGAL AGENTS IN THE UNITED STATES OUTPATIENT MEDICAID POPULATION- 1991-2009

    May 1, 2011, 00:00

  • PND30 QUALITY OF LIFE AMONG PATIENTS SUFFERING FROM MIGRAINE- HEALTH UTILITY BY FREQUENCY OF HEADACHE DAYS

    May 1, 2011, 00:00

  • PRM42 VISUALLY EVALUATING THE MEASUREMENT COMPARABILITY BETWEEN PAPER-BASED AND ALTERNATE VERSIONS OF ADMINISTRATION OF THE LUNG FUNCTION QUESTIONNAIRE

    May 1, 2011, 00:00

  • PHP80 RELATIONSHIP OF HERBAL KNOWLEDGE TOWARDS ATTITUDE FORMATION AMONG FUTURE PHARMACISTS

    May 1, 2011, 00:00

  • PSS29 DEVELOPMENT OF THE MODIFIED OCULAR COMFORT INDEX (MOCI)

    May 1, 2011, 00:00

  • PSY50 PRESCRIPTION MONITORING PROGRAMS' UTILIZATION

    May 1, 2011, 00:00

  • PND62 MEDICATION POSSESSION RATIO (MPR)- A COMPARISON OF TRADITIONAL MPR AND MODIFIED MPR FOR MULTIPLE SCLEROSIS (MS) PATIENTS PRESCRIBED DISEASE MODIFYING DRUGS (DMDS)

    May 1, 2011, 00:00

  • PRM10 IS IT FEASIBLE TO COLLECT QUALITY OF LIFE DATA ELECTRONICALLY IN THIN - A UK GENERAL PRACTICE DATABASE?

    May 1, 2011, 00:00

  • PDB16 DIABETES MELLITUS TYPE 2 AND T2DM PLUS HYPERTENSION IN BRAZIL- THE EPIDEMIOLOGIC PROFILE OF THE POPULATION REGISTERED IN THE GOVERNMENT PROGRAM HIPERDIA

    May 1, 2011, 00:00

  • PMH5 PSYCHIATRIC ADVERSE EFFECTS RELATED TO PRESCRIPTION OF METHYLPHENIDATE IN TAIWAN

    May 1, 2011, 00:00

  • PGI10 EXAMINATION OF RESOURCE UTILIZATION PATTERNS ACROSS SUBGROUPS OF GASTROESOPHAGEAL REFLUX DISEASE PATIENTS

    May 1, 2011, 00:00

  • PCN66 COST-MINIMIZATION ANALYSIS OF THE USE OF RASBURICASE IN TUMOR LYSIS SYNDROME IN PEDIATRIC ONCOLOGY

    May 1, 2011, 00:00

  • PIH41 SUCCESSFUL SEXUAL INTERCOURSE- TIME-TO-EVENT MODELING IN A SILDENAFIL TRIAL

    May 1, 2011, 00:00

  • PHP27 CANADIAN PUBLIC DRUG PROGRAM SPENDING ON SENIORS, 2002 TO 2008

    May 1, 2011, 00:00

  • PIN13 IMPACT OF NEWLY DIAGNOSED HEPATITIS C INFECTIONS ON HEALTH CARE COSTS

    May 1, 2011, 00:00

  • PCV26 EFFECTS OF THIAZOLIDINEDIONES ON CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE-2 DIABETES MELLITUS AFTER DRUG-ELUTING STENT IMPLANTATION

    May 1, 2011, 00:00

  • PGI9 COMPARISON OF DIRECT MEDICAL COSTS AND SERVICES BY POINT OF SERVICE AND PRESCRIPTION COST FOR PERSONS WITH HEPATITIS-C WITH AND WITHOUT TREATMENT

    May 1, 2011, 00:00

  • PND60 TESTING A COMPUTERIZED METHOD OF ASSESSING MOVEMENT ACCURACY

    May 1, 2011, 00:00

  • PCN46 HEALTH CARE EXPENDITURES, DISABILITY DAYS, AND RESOURCE UTILIZATION ASSOCIATED WITH CANCER IN EMPLOYER SETTINGS IN THE UNITED STATES

    May 1, 2011, 00:00

  • PCN94 HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN 1ST LINE NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS IN A REAL LIFE SETTING- BEVACIZUMAB-BASED VERSUS NON-BEVACIZUMAB BASED THERAPY IN A EUROPEAN PILOT STUDY

    May 1, 2011, 00:00

  • PND32 HEALTH RESOURCE UTILIZATION AND COSTS FOR MIGRANEURS IN SCOTLAND

    May 1, 2011, 00:00

  • PCN72 GENE EXPRESSION PROFILING FOR GUIDING ADJUVANT CHEMOTHERAPY DECISIONS IN WOMEN WITH EARLY BREAST CANCER- A COST-EFFECTIVENESS ANALYSIS OF 1000 STRATEGIES FOR THE PROVISION OF ADJUVANT! ONLINE, ONCOTYPE DX AND CHEMOTHERAPY

    May 1, 2011, 00:00

  • PDB5 THE IMPACT OF ANTIDIABETIC-INDUCED HYPOGLYCEMIA ON CLINICAL OUTCOMES AND RESOURCE UTILIZATION AMONG VETERANS WITH TYPE-2 DIABETES MELLITUS (T2DM)

    May 1, 2011, 00:00

  • PMS13 OSTEOPOROSIS-RELATED FRACTURE COSTS AMONG FEMALE COMMERCIALLY INSURED AND MEDICARE PATIENTS

    May 1, 2011, 00:00

  • PRM20 TRENDS IN UTILITY ELICITATION METHODS- DIRECT VERSUS INDIRECT METHODS

    May 1, 2011, 00:00

  • PDB28 COST SAVINGS IN TYPE-2 DIABETES (T2D) WITH INSULIN GLARGINE COMPARED WITH INSULIN DETEMIR IN THE UNITED KINGDOM

    May 1, 2011, 00:00

  • PCN88 ATTITUDES OF YOUNG WOMEN ON HUMAN PAPILLOMA VIRUS VACCINATION

    May 1, 2011, 00:00

  • PCV44 CHANGING COST-EFFECTIVENESS EARLY IN THE PRODUCT LIFE CYCLE- THE EXAMPLE OF CLOPIDOGREL BISULFATE

    May 1, 2011, 00:00

  • EV4 MORE BANG FOR YOUR BUCK- TAKE A RISK WHEN ANALYSING INTERVIEW DATA

    May 1, 2011, 00:00

  • PIH38 EPIDEMIOLOGY OF ADOLESCENT AND YOUNG ADULT HOSPITAL UTILIZATION FOR ALCOHOL AND DRUG USE, SUICIDE, AND POISONING IN THE UNITED STATES

    May 1, 2011, 00:00

  • PCV87 FACTORS ASSOCIATED WITH SELECTIONS OF STATINS AMONG ELDERLY PATIENTS

    May 1, 2011, 00:00

  • PCV105 THE INITIATION AND EXTENT OF DOSE TITRATION OF ACE INHIBITORS AND β-BLOCKERS POST ACUTE MYOCARDIAL INFARCTION- A PROSPECTIVE AUDIT

    May 1, 2011, 00:00

  • CN4 PALONOSETRON VERSUS OTHER 5-HYDROXYTRYPTAMINE3 RECEPTOR ANTAGONISTS FOR PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING AMONG MEDICARE PATIENTS WITH CANCER

    May 1, 2011, 00:00

  • QA1 COST-EFFECTIVENESS OF DUTASTERIDE AS A CHEMOPREVENTION IN PROSTATE CANCER- REDUCE WITHIN-TRIAL ANALYSIS

    May 1, 2011, 00:00

  • PND56 COMPARISON OF THE HEALTH CARE UTILIZATION AND COSTS OF MEDICALLY MANAGED PATIENTS VERSUS DEEP BRAIN STUMULATION PATIENTS WITH PARKINSON'S DISEASE

    May 1, 2011, 00:00

  • PMD13 POST INGUINAL HERNIA REPAIR PAIN MANAGEMENT COSTS- A STUDY USING THE PREMIER PERSPECTIVE ™ DATABASE (PPD)

    May 1, 2011, 00:00

  • PND28 THE RELATIONSHIP BETWEEN ALTERNATIVE MEDICATION POSESSION RATIO THRESHOLDS AND OUTCOMES- EVIDENCE FROM THE USE OF GLATIRAMER ACETATE

    May 1, 2011, 00:00

  • SB3 INNOVATIVE DESIGN FOR A COMPARATIVE EFFECTIVENESS STUDY OF SCHIZOPHRENIA TREATMENTS- ANALYSIS OF RECORD REVIEW DATA INCORPORATING RANDOMIZATION AND PROPENSITY SCORE MATCHING

    May 1, 2011, 00:00

  • PRM18 CAN UTILITIES EXCEED 1.0? EMPIRICAL EVIDENCE OF THE CEILING EFFECT

    May 1, 2011, 00:00

  • PRM32 VALIDITY EVIDENCE AND VALIDATION PRACTICE IN PAPERS PUBLISHED IN VALUE IN HEALTH (1998-2010)- A SYSTEMATIC REVIEW

    May 1, 2011, 00:00

  • PDB27 COST-EFFECTIVENESS ANALYSIS OF METFORMIN COMBINED WITH SAXAGLIPTIN VERSUS METFORMIN COMBINED WITH SULFONYLUREAS IN TYPE-2 DIABETES PATIENTS IN CHILE

    May 1, 2011, 00:00

  • PCN102 SYNCHRONIZATION OF ADMINISTRATIONS OF CHEMOTHERAPY AND ERYTHROPOIESIS-STIMULATING AGENTS AND FREQUENCY OF ASSOCIATED HEALTH CARE VISITS

    May 1, 2011, 00:00

  • PMH40 COST-EFFECTIVENESS AND BUDGET IMPACT OF ADJUNCT QUETIAPINE FUMARATE EXTENDED-RELEASE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER WITH AN INADEQUATE RESPONSE TO PREVIOUS THERAPY

    May 1, 2011, 00:00

  • PUK9 MEDICAL CARE SPENDING ASSOCIATED WITH CHRONIC KIDNEY DISEASE BY STAGE OF DISEASE- A POPULATION-BASED STUDY

    May 1, 2011, 00:00

  • PRM33 TAKE TIME TO TRAIN- EVIDENCE TO SHOW THAT PATIENT TRAINING IN ELECTRONIC PATIENT REPORTED OUTCOMES IS BENEFICIAL

    May 1, 2011, 00:00

  • PSU25 IDENTIFYING IMPROVEMENT OF PRESSURE ULCER PREVENTION AT THE POINT-OF-CARE WITH MULTIPLE METHODS IN THE DEPARTMENT OF SURGERY

    May 1, 2011, 00:00

  • DS1 INTEGRATING DATA SOURCES TO CONDUCT COMPREHENSIVE ONCOLOGY BASED OUTCOMES RESEARCH

    May 1, 2011, 00:00

  • PDB17 ASSOCIATION OF YOUNGER AGE WITH POOR GLYCAEMIC AND CHOLESTEROL CONTROL IN ASIANS WITH TYPE-2 DIABETES IN SINGAPORE

    May 1, 2011, 00:00

  • PND59 MEDICATION TREATMENT PATTERNS FOR MULTIPLE SCLEROSIS PATIENTS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM

    May 1, 2011, 00:00

  • PDB2 EVALUATING ONE-YEAR STABILITY OF THE TOTAL ILLNESS BURDEN INDEX

    May 1, 2011, 00:00

  • PCV31 ASSOCIATION BETWEEN HEART FAILURE AND IN-HOSPITAL MORTALITY IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTION

    May 1, 2011, 00:00

  • PDB29 DIRECT MEDICAL COST OF HYPOGLYCEMIA AMONG PATIENTS WITH TYPE-2 DIABETES IN THE UNITED STATES

    May 1, 2011, 00:00

  • Editorial Board

    May 1, 2011, 00:00

  • PRM8 LEGAL RESTRICTIONS ON THE USE OF QALYS IN PHARMACOECONOMIC ANALYSIS IN GERMANY

    May 1, 2011, 00:00

  • PDB53 PRESCRIBING PATTERN OF ANTIDIABETIC DRUGS IN T2DM PATIENTS TERTIARY CARE HOSPITAL IN INDIA

    May 1, 2011, 00:00

  • ISPOR 16th Annual International Meeting Financial Disclosure Information for Research Presentations

    May 1, 2011, 00:00

  • Table of Contents

    May 1, 2011, 00:00

  • PSY70 ASSOCIATION OF PROVIDER CONTINUITY WITH HOSPITALIZATION AMONG FLORIDA MEDICAID ENROLLEES WITH SICKLE CELL DISEASE (SCD)

    May 1, 2011, 00:00

  • PIN53 COMPARISON OF EVIDENCE-BASED VARIATION AND CONSTANT PERCENTAGE VARIATION FOR ONE-WAY SENSITIVITY ANALYSES

    May 1, 2011, 00:00

  • PDB68 ASSESSING LIFEYEARS SAVED FROM 2000 TO 2010 IN CHINA DUE TO NOVO NORDISK INSULIN

    May 1, 2011, 00:00

  • PHP73 SYSTEMATIC LITERATURE REVIEW ON HETEROGENEITY OF RELATIVE EFFECTIVENESS AND RELATIVE EFFICACY OF MEDICINES IN EUROPE

    May 1, 2011, 00:00

  • PSY59 IMPACT OF OBESITY ON AGE-SPECIFIC PREVALENCE OF CHRONIC DISEASES IN THE UNITED STATES

    May 1, 2011, 00:00

  • PHP93 AN EXAMINATION OF HOSPITAL-ACQUIRED CONDITIONS BY AGE AND PAYER IN FIFTEEN STATES, 2008

    May 1, 2011, 00:00

  • PHP90 TRENDS IN UTILIZATION OF PREGNANCY RISK CATEGORY D AND X DRUGS AMONG PREGNANT WOMEN IN THE UNITED STATES

    May 1, 2011, 00:00

  • PUK17 UTILIZATION AND ECONOMIC IMPACT OF IV IRON AND ERYTHROPOIESIS STIMULATING AGENTS IN CHRONIC KIDNEY DISEASE PATIENTS- A MULTI-HOSPITAL STUDY

    May 1, 2011, 00:00

  • PND51 THE EFFECT OF THE MEDICARE PART D COVERAGE GAP AND OUT-OF-POCKET BURDEN ON THE USE OF DISEASE MODIFYING DRUGS TO TREAT MULTIPLE SCLEROSIS

    May 1, 2011, 00:00

  • PSY56 CONTROLLED SUBSTANCE PRESCRIBING AND UTILIZATION OF PRESCRIPTION DRUG MONITORING PROGRAMS

    May 1, 2011, 00:00

  • PCN26 BUDGET IMPACT MODEL OF DENOSUMAB FOR SKELETAL RELATED EVENT (SRE) PREVENTION IN PATIENTS WITH BREAST AND PROSTATE CANCER

    May 1, 2011, 00:00

  • PSY49 PREDICTORS OF OBESITY TREATMENT (COUNSELING OR PHARMACOTHERAPY) IN AMBULATORY SETTINGS

    May 1, 2011, 00:00

  • PIN31 COST-EFFECTIVENESS ANALYSIS OF DIFFERENT APPROACHES TO THE DIAGNOSIS AND TREATMENT OF INFLUENZA-LIKE ILLNESS IN HEALTHY ADULTS

    May 1, 2011, 00:00

  • PIH12 INPATIENT COSTS OF LOW BIRTH WEIGHT AND PRE-TERM INFANTS IN THE UNITED STATES IN 2008

    May 1, 2011, 00:00

  • PHP69 HOW MUCH FOR A QALY IN KOREA

    May 1, 2011, 00:00

  • PDB4 MODELING HEALTH AND ECONOMIC OUTCOMES ASSOCIATED WITH EXENATIDE ONCE-WEEKLY VERSUS INSULIN AND PIOGLITAZONE TREATMENT FOR TYPE-2 DIABETES

    May 1, 2011, 00:00

  • PRM44 OPTIMUM METHODS FOR PRO TRANSLATION AND LINGUISTIC VALIDATION METHODOLOGY- ONE BACK TRANSLATION OR TWO?

    May 1, 2011, 00:00

  • PHP53 A RAPID EVALUATION UNIT INCREASES EMERGENCY DEPARTMENT VISITS

    May 1, 2011, 00:00

  • PRM48 DESIGN AND OPERATIONAL CONSIDERATIONS FOR PRAGMATIC CLINICAL TRIALS TO SUPPORT HEOR EVALUATIONS

    May 1, 2011, 00:00

  • PDB38 A COMPARISON OF INSULIN ADHERENCE IN PATIENTS WITH TYPE-2 DIABETES INITIATING THERAPY WITH INSULIN DETEMIR FLEXPEN® OR NPH INSULIN IN A VIAL

    May 1, 2011, 00:00

  • PIH1 HEALTH-RELATED QUALITY OF LIFE (HRQOL) OF PATIENTS WITH CHRONIC CONDITIONS- EXCESS BURDEN OF COMORBID PHYSICAL AND MENTAL CHRONIC CONDITIONS

    May 1, 2011, 00:00

  • PHP100 PRICING AND REIMBURSEMENT OF ORPHAN DRUGS IN CANADA

    May 1, 2011, 00:00

  • PHP37 A REGISTRY PERSPECTIVE OF OF HOSPITAL DISCHARGE COSTS- PILOT RESULTS OF THE 10 MOST FREQUENT DIAGNOSIS AND PROCEDURES OF THE ARGENTINE-HEALTH CARE COST AND UTILIZATION PROJECT (A-HCUP)

    May 1, 2011, 00:00

  • PCN36 COST ANALYSIS, SAFETY, AND EFFICACY OF PEMETREXED/CISPLATIN COMPARED WITH BEVACIZUMAB/GEMCITABINE/CISPLATIN IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED NON-SQUAMOUS NSCLC IN RUSSIA

    May 1, 2011, 00:00

  • PHP70 PREVENTABLE HOSPITALIZATIONS AND HEALTH INSURANCE COVERAGE IN HARRIS COUNTY, TEXAS

    May 1, 2011, 00:00

  • PSU24 AGREEMENT BETWEEN PROMIS DEPRESSION, SLEEP DISTURBANCE, AND FATIGUE CAT MEASURES AND SF-36 SCORES IN A CLINICAL COHORT

    May 1, 2011, 00:00

  • PRM26 IMPACT OF A WEB PORTAL TOOL ON DRIVING PATIENT ADHERENCE

    May 1, 2011, 00:00

  • PHP62 WHAT IS THE IMPACT OF COMPARATIVE EFFECTIVENESS AND VALUE BASED PRICING ON A PRODUCT'S VALUE AND MARKET ACCESS?

    May 1, 2011, 00:00

  • PMH11 PERFORMANCE OF RISK ADJUSTMENT SCALES IN PREDICTING RISK OF HOSPITALIZATION AMONG DEMENTIA PATIENTS- A MEPS STUDY

    May 1, 2011, 00:00

  • PMS6 THE PREVALENCE OF BONE FRACTURES IN OSTEOPOROSIS PATIENTS USING PROTON PUMP INHIBITORS

    May 1, 2011, 00:00

  • PND22 QUANTIFYING COST OUTCOMES DIFFERENTIATED BY GENDER AND AGE IN THE TREATMENT OF MIGRAINE HEADACHE USING STEP AND STRATIFIED CARE

    May 1, 2011, 00:00

  • PND57 TEMPORAL TRENDS AND GEOGRAPHIC DISCREPANCIES IN PUBLIC EXPENDITURES WITH MULTIPLE SCLEROSIS DRUG TREATMENT IN BRAZIL

    May 1, 2011, 00:00

  • PHP51 MORTALITY AFTER SPOUSAL BEREAVEMENT IN BENEFICIARIES OF THE HEALTH PLAN

    May 1, 2011, 00:00

  • PMS66 EARLY AND SUSTAINED REMISSION ASSOCIATED WITH NORMALIZED PHYSICAL FUNCTION AND HEALTH-RELATED QUALITY OF LIFE AND SIGNIFICANTLY IMPROVED PRODUCTIVITY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS TREATED WITH GOLIMUMAB- TWO YEAR DATA FR ...

    May 1, 2011, 00:00

  • PMS61 INFLIXIMAB INFUSION PATTERNS IN PATIENTS WITH RHEUMATOID ARTHRITIS ‘NAïVE' TO BIOLOGIC THERAPY- AN ANALYSIS OF A NATIONAL HEALTH PLAN

    May 1, 2011, 00:00

  • PIH9 COSTS TO THE NATIONAL HEALTH INSURACE SCHEME OF THE FREE MATERNAL HEALTH SERVICE CHALLENGES AND IMPLICATIONS FOR SUSTAINABILITY IN GHANA

    May 1, 2011, 00:00

  • PIN3 A META-ANALYSIS OF EFFICACY AND SAFETY OF LINEZOLID FOR INFECTED DIABETIC FOOT TREATMENT

    May 1, 2011, 00:00

  • PSY68 DEFINITIONS OF ANTI-TNF DISCONTINUATION MAY IMPACT UNDERSTANDING OF REAL-WORLD UTILIZATION PATTERNS

    May 1, 2011, 00:00

  • PCN11 COMPARATIVE EFFECTIVENESS RESEARCH- ERECTILE DYSFUNCTION LONGITUDINAL COSTS ACROSS TREATMENTS FOR PROSTATE CANCER

    May 1, 2011, 00:00

  • PND43 THE PATIENTSLIKEME® EPILEPSY COMMUNITY- A UNIQUE INSIGHT INTO THE LIVES OF PATIENTS WITH EPILEPSY

    May 1, 2011, 00:00

  • PMS63 SATISFACTION, PREFERENCE AND REASONS FOR BIOLOGIC TREATMENT DISCONTINUATION IN PATIENTS WITH RHEUMATOID ARTHRITIS

    May 1, 2011, 00:00

  • PRM17 DEVELOPMENT AND VALIDATION OF A HEALTH RELATED QUALITY OF LIFE INSTRUMENT TO MEASURE THE IMPACT OF OVER-THE-COUNTER PRODUCT USE AND ASSOCIATED ADVERSE EVENTS

    May 1, 2011, 00:00

  • PSS27 EFFECT OF TREATMENT SWITCH ON THE COST-EFFECTIVENESS OF BIOLOGICS IN PSORIASIS IN PERU AND COLOMBIA

    May 1, 2011, 00:00

  • PIH20 ECONOMIC EVALUATION OF THE USE OF EXOGENOUS PULMONARY SURFACTANTS IN PRETERM NEWBORNS WITH RESPIRATORY DISTRESS SYNDROME IN MEXICAN POPULATION COVERED BY THE NEW GENERATION MEDICAL INSURANCE

    May 1, 2011, 00:00

  • PIN19 COST-BENEFIT ANALYSIS OF POSTPARTUM VACCINATION OF BIRTH MOTHERS WITH INFLUENZA VACCINE

    May 1, 2011, 00:00

  • PCV63 THE IMPACT OF CARDIOVASCULAR DISEASE HOSPITALIZATIONS ON CHANGES IN PATIENT ADHERENCE TO ANTIHYPERTENISVE DRUGS IN A MEDICAID POPULATION

    May 1, 2011, 00:00

  • PCV90 FACTORS ASSOCIATED WITH SELECTIONS OF STATINS AMONG PATIENTS IN A LARGE EMPLOYER-BASED CLAIMS DATABASE

    May 1, 2011, 00:00

  • PCN23 IMPACT OF US FOOD AND DRUG ADMINISTRATION'S BLACK BOX WARNINGS ON ADVERSE EVENTS REPORTING RATES FOR MULTIPLE MYELOMA DRUGS

    May 1, 2011, 00:00

  • PHP77 THE STATE OF HEALTH ECONOMICS AND PHARMACOECONOMICS RESEARCH IN RUSSIA- A SYSTEMATIC REVIEW

    May 1, 2011, 00:00

  • PRS2 INCREASED PREVALENCE OF OBSTRUCTIVE LUNG DISEASE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA

    May 1, 2011, 00:00

  • PMH30 INDIRECT COSTS (IC) OF ADULT WOMEN WITH ANXIETY DISORDERS (AD) IN THE UNITED STATES IN 2006 FROM THE MEDICAL EXPENDITURES PANEL SURVEY (MEPS)

    May 1, 2011, 00:00

  • PRM37 THE DISCRETE MODELLING OF INTERVENTIONS WITH CONTINUOUSLY VARYING COSTS AND EFFECTS- IMPLICATIONS FOR ICERS, CEACS AND EVPI

    May 1, 2011, 00:00

  • PCV71 EVALUATING MEDICATION ADHERENCE WITH CHRONIC CARDIOVASCULAR THERAPIES AMONG UNINSURED WORKING ADULTS- RESULTS FROM THE TEXAS DEMONSTRATION TO MAINTAIN INDEPENDENCE AND EMPLOYMENT (DMIE) STUDY

    May 1, 2011, 00:00

  • PCN132 MODELING THE LIFETIME EFFECTIVENESS OF DENOSUMAB AND ZOLEDRONIC ACID (ZA) IN THE PREVENTION OF SKELETAL RELATED EVENTS (SRE) IN PATIENTS WITH BONE METASTASES FROM SOLID TUMORS

    May 1, 2011, 00:00

  • PMS24 THE COST EFFECTIVENESS OF STRONTIUM RANELATE VERSUS RISEDRONATE, RALOXIFENE, IBANDRONATE, ALENDRONATE AND CALCITONIN IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROTIC WOMEN IN TURKEY

    May 1, 2011, 00:00
  • «
  • 131
  • 132 (current)
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • »